Heme-associated parasite proteins (HDP (for Heme detoxification protein, Plasmodium))

Heme-associated parasite proteins comprise a heterogeneous group of molecules used by parasites such as Plasmodium and blood-feeding arthropods to bind, transport, sequester, or detoxify heme derived from host hemoglobin. In malaria parasites, the Heme detoxification protein (HDP) is critical for converting toxic free heme into inert hemozoin crystals within the digestive vacuole. This pathway is unique to parasites and is the target of several antimalarial compounds, notably the quinoline drugs. Some parasites also express divergent heme oxygenase–like proteins (e.g., PfHO in Plasmodium falciparum), which though no longer enzymatically active, serve regulatory functions vital to parasite survival. In blood-feeding arthropods, heme-binding proteins such as CP and Vg function to bind, transport, and sequester heme, mitigating heme-induced toxicity. Targeting these distinct detoxification or handling mechanisms is a validated and ongoing area of parasitic disease drug discovery, particularly in malaria. In summary, "heme-associated parasite proteins" does not refer to a single, well-defined therapeutic target, but rather a class of proteins involved in parasite heme metabolism, of which HDP is the best-characterized therapeutic target, especially for malaria drug development. [is_incorrect: true for the overarching non-canonical grouping; use specific canonical forms such as "Heme detoxification protein" (HDP) or "Hemelipoglyco-carrier protein" where possible.]

Other names

Heme detoxification proteinHDPhemelipoglyco-carrier protein (CP)vitellogenin (Vg)PfHO (heme oxygenase–like protein in Plasmodium falciparum)

Inhibition of heme detoxification/crystallization into hemozoin (antimalarials like chloroquine bind to heme or interfere with HDP’s role or the hemozoin pathway, leading to toxic heme accumulation)